Literature DB >> 7936179

3D-FT thin sections MRI of prolactin-secreting pituitary microadenomas.

N Girard1, T Brue, V Chabert-Orsini, C Raybaud, P Jaquet, M Poncet, F Grisoli, S Cahen.   

Abstract

We studied 76 patients with endocrinological features of prolactin-secreting microadenoma by MRI, using three dimensional (3D) gradient echo acquisition (FLASH) sequences. MRI revealed a focal signal abnormality in the pituitary in all 37 patients who had not previously taken bromocriptine. However, focal abnormality was shown in only half the patients had been on dopamine agonist therapy; the MRI findings in these 39 patients were not affected by the duration and dosage bromocriptine, nor by the time elapsed since its discontinuation. The microadenoma gave spontaneous high signal on the unenhanced T1-weighted images in 8 cases; it was not seen on unenhanced images in 25 cases. It appeared as low signal within the enhancing gland in 51 cases but enhanced in 7 cases. The 3D technique gives thin (1 mm) slices and therefore facilitates detection of small focal abnormalities in the pituitary gland (2 x 2 mm). In the 19 previously treated patients in whom MRI did not demonstrate a focal abnormality, it showed localised atrophy of the gland in 3, a large, round gland with homogeneous signal in 1, and a heterogeneous appearance in 11; it was normal in 4 cases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7936179     DOI: 10.1007/bf00612122

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  20 in total

1.  [Evaluation of nuclear magnetic resonance imaging in tridimensional acquisition in the investigation of prolactin microadenoma].

Authors:  N Girard; L Cortesi; V Chabert-Orsini; P Maman; T Brue; P Jaquet; C Raybaud
Journal:  Ann Endocrinol (Paris)       Date:  1992       Impact factor: 2.478

2.  Explanation and implications of MR signal changes within pituitary adenomas after bromocriptine therapy.

Authors:  S S Weissbuch
Journal:  AJNR Am J Neuroradiol       Date:  1986 Mar-Apr       Impact factor: 3.825

3.  MR imaging of pituitary adenoma: CT, clinical, and surgical correlation.

Authors:  P C Davis; J C Hoffman; T Spencer; G T Tindall; I F Braun
Journal:  AJR Am J Roentgenol       Date:  1987-04       Impact factor: 3.959

4.  Microadenomas of the human pituitary and their vascularization.

Authors:  W Gorczyca; J Hardy
Journal:  Neurosurgery       Date:  1988-01       Impact factor: 4.654

5.  Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging.

Authors:  Y Miki; M Matsuo; S Nishizawa; Y Kuroda; A Keyaki; Y Makita; J Kawamura
Journal:  Radiology       Date:  1990-10       Impact factor: 11.105

6.  Sellar susceptibility artifacts: theory and implications.

Authors:  A D Elster
Journal:  AJNR Am J Neuroradiol       Date:  1993 Jan-Feb       Impact factor: 3.825

7.  Human prolactin-producing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural, and morphometric study.

Authors:  G T Tindall; K Kovacs; E Horvath; M O Thorner
Journal:  J Clin Endocrinol Metab       Date:  1982-12       Impact factor: 5.958

8.  Pituitary microadenomas: diagnosis with two-and three-dimensional MR imaging at 1.5 T before and after injection of gadolinium.

Authors:  T Stadnik; A Stevenaert; A Beckers; R Luypaert; T Buisseret; M Osteaux
Journal:  Radiology       Date:  1990-08       Impact factor: 11.105

9.  Morphological evidence for the presence of arteries in human prolactinomas.

Authors:  J Schechter; P Goldsmith; C Wilson; R Weiner
Journal:  J Clin Endocrinol Metab       Date:  1988-10       Impact factor: 5.958

10.  Pituitary adenoma: correlation of half-dose gadolinium-enhanced MR imaging with surgical findings in 26 patients.

Authors:  P C Davis; K A Gokhale; G J Joseph; S B Peterman; D A Adams; G T Tindall; P A Hudgins; J C Hoffman
Journal:  Radiology       Date:  1991-09       Impact factor: 11.105

View more
  1 in total

1.  Magnetic resonance imaging of the normal pituitary gland using ultrashort TE (UTE) pulse sequences (REV 1.0).

Authors:  Olivia Portman; Stephen Flemming; Jeremy P D Cox; Desmond G Johnston; Graeme M Bydder
Journal:  Neuroradiology       Date:  2007-11-22       Impact factor: 2.804

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.